Furthermore, it has been proposed that the dual γ/δ inhibitor CAL-130, specifically targeting p110γ and p110δ isoforms in PTEN deleted T-ALL cell lines [100]. The gene discussed is PTEN; the disease is acute lymphoblastic leukemia.